Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers (PDF 996 KB)

  Published:

  14 August 2019

• Appraisal consultation committee papers (PDF 3.97 MB)

  Published:

  14 August 2019